Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $40,830 | 2 | 99.7% |
| Food and Beverage | $119.22 | 1 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $40,830 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $119.22 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $119.22 | 1 | GlaxoSmithKline, LLC. ($119.22) |
| 2018 | $40,830 | 2 | Eli Lilly and Company ($40,830) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $119.22 | General |
| Category: IMMUNOLOGY | ||||||
| 07/05/2018 | Eli Lilly and Company | TALTZ (Drug) | — | Cash or cash equivalent | $14,466.00 | Research |
| Study: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED 24-WEEK STUDY FOLLOWED BY LONG TERM EVALUATION OF EFFICACY AND SAFETY OF IXEKIZUMAB LY2439821 IN BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG-EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS • Category: Immunology | ||||||
| 07/03/2018 | Eli Lilly and Company | TALTZ (Drug) | — | Cash or cash equivalent | $26,364.12 | Research |
| Study: A PHASE 3, MULTICENTER STUDY WITH A 36-WEEK OPEN-LABEL PERIOD FOLLOWED BY A RANDOMIZED DOUBLE-BLIND WITHDRAWAL PERIOD FROM WEEK 36 TO WEEK 104 TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF IXEKIZUMAB -LY2439821- 80 MG EVERY 2 WEEKS IN BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS • Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, MULTICENTER STUDY WITH A 36-WEEK OPEN-LABEL PERIOD FOLLOWED BY A RANDOMIZED DOUBLE-BLIND WITHDRAWAL PERIOD FROM WEEK 36 TO WEEK 104 TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF IXEKIZUMAB -LY2439821- 80 MG EVERY 2 WEEKS IN BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS | Eli Lilly and Company | $26,364 | 1 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED 24-WEEK STUDY FOLLOWED BY LONG TERM EVALUATION OF EFFICACY AND SAFETY OF IXEKIZUMAB LY2439821 IN BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG-EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS | Eli Lilly and Company | $14,466 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 109 | 113 | $25,809 | $5,989 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 42 | $13,854 | $3,105 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 50 | $11,598 | $2,821 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 20 | 21 | $357.00 | $63.00 | 17.6% |
About Dr. Melodie Armstrong, MD
Dr. Melodie Armstrong, MD is a Family Medicine healthcare provider based in Martinez, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093821779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melodie Armstrong, MD has received a total of $40,949 in payments from pharmaceutical and medical device companies, with $119.22 received in 2021. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "" ($40,830).
As a Medicare-enrolled provider, Armstrong has provided services to 109 Medicare beneficiaries, totaling 113 services with total Medicare billing of $5,989. Data is available for 1 year (2022–2022), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Martinez, CA
- Active Since 08/22/2006
- Last Updated 10/01/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1093821779
Products in Payments
- TALTZ (Drug) $40,830
- BENLYSTA (Biological) $119.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Martinez
Brent Porteous, D.o, D.O
Family Medicine — Payments: $54,795
Melissa Hubiak
Family Medicine — Payments: $4,853
Dr. Richard Carpenter, D.o., Ph.d, D.O., PH.D
Family Medicine — Payments: $3,320
Craig Desoer
Family Medicine — Payments: $2,927
Dr. Roger Brown, Md, MD
Family Medicine — Payments: $2,737
Benjamin Towe, Md, MD
Family Medicine — Payments: $2,022